Cite
HARVARD Citation
Miyamoto, S. et al. (2022). Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study. Diabetes, obesity & metabolism. 24 (8), pp. 1429-1438. [Online].